de Queiroz Mayara Ribeiro, de Sousa Bruna Barbosa, da Cunha Pereira Déborah Fernanda, Mamede Carla Cristine Neves, Matias Mariana Santos, de Morais Nadia Cristina Gomes, de Oliveira Costa Júnia, de Oliveira Fábio
Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil; Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica (N-Biofar), Belo Horizonte, MG, Brazil.
Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil.
Toxicon. 2017 Jul;133:33-47. doi: 10.1016/j.toxicon.2017.04.013. Epub 2017 Apr 20.
The human body has a set of physiological processes, known as hemostasis, which keeps the blood fluid and free of clots in normal vessels; in the case of vascular injury, this process induces the local formation of a hemostatic plug, preventing hemorrhage. The hemostatic system in humans presents complex physiological interactions that involve platelets, plasma proteins, endothelial and subendothelial structures. Disequilibrium in the regulatory mechanisms that control the growth and the size of the thrombus is one of the factors that favors the development of diseases related to vascular disorders such as myocardial infarction and stroke, which are among the leading causes of death in the western world. Interfering with platelet function is a strategy for the treatment of thrombotic diseases. Antiplatelet drugs are used mainly in cases related to arterial thrombosis and interfere in the formation of the platelet plug by different mechanisms. Aspirin (acetylsalicylic acid) is the oldest and most widely used antithrombotic drug. Although highly effective in most cases, aspirin has limitations compared to other drugs used in the treatment of homeostatic disorders. For this reason, research related to molecules that interfere with platelet aggregation are of great relevance. In this regard, snake venoms are known to contain a number of molecules that interfere with hemostasis, including platelet function. The mechanisms by which snake venom components inhibit or activate platelet aggregation are varied and can be used as tools for the diagnosis and the treatment of several hemostatic disorders. The aim of this review is to present the role of platelets in hemostasis and the mechanisms by which snake venom toxins interfere with platelet function.
人体有一套生理过程,称为止血,它能使血液在正常血管中保持流动且无凝块;在血管受损时,这一过程会诱导局部形成止血栓,防止出血。人体的止血系统呈现出复杂的生理相互作用,涉及血小板、血浆蛋白、内皮和内皮下结构。控制血栓生长和大小的调节机制失衡是导致与血管疾病相关疾病(如心肌梗死和中风)发展的因素之一,这些疾病是西方世界主要的死亡原因。干扰血小板功能是治疗血栓性疾病的一种策略。抗血小板药物主要用于与动脉血栓形成相关的病例,并通过不同机制干扰血小板栓的形成。阿司匹林(乙酰水杨酸)是最古老且使用最广泛的抗血栓药物。尽管在大多数情况下非常有效,但与用于治疗止血紊乱的其他药物相比,阿司匹林有其局限性。因此,与干扰血小板聚集的分子相关的研究具有重要意义。在这方面,已知蛇毒含有多种干扰止血的分子,包括血小板功能。蛇毒成分抑制或激活血小板聚集的机制各不相同,可作为诊断和治疗多种止血紊乱的工具。本综述的目的是介绍血小板在止血中的作用以及蛇毒毒素干扰血小板功能的机制。